Literature DB >> 31234758

Characteristics of Moyamoya Disease Based on National Registry Data in Japan.

Yoko Sato1, Ken Kazumata2, Eiji Nakatani3, Kiyohiro Houkin2, Yasuhiro Kanatani4.   

Abstract

Background and Purpose- A public registration system for intractable diseases was started in Japan in 1972 to investigate the etiology and pathogenesis of intractable diseases while reducing out-of-pocket medical expenses on patients. The goal of this study was to investigate the epidemiology and clinical characteristics of Moyamoya disease using data from applications submitted to this system between 2004 and 2008. Methods- In addition to demographic factors such as onset age and family history, we evaluated clinical presentation type, imaging findings, clinical symptoms, and functioning in activities of daily living (ADL). Results- Of 3859 cases for which applications were submitted, 2545 were confirmed to meet the diagnostic criteria after data cleansing. Onset age showed a bimodal distribution, and Moyamoya disease had a higher incidence in women than in men. The presence of occlusion and infarction in the proximal region of the anterior cerebral artery was more frequent in pediatric cases than adult cases. Our findings also indicated that 23% of patients required assistance with ADL. Cerebral infarction (odds ratio [OR], 12.5; 95% CI, 3.55-44.66), seizure (OR, 7.44; 95% CI, 1.29-42.96), and sensory disorders (OR, 5.23; 95% CI, 1.15-23.75) were identified as significant predictors of impaired ADL in pediatric cases 3 years after the initial application. Moderate ADL function (OR, 11.59; 95% CI, 5.29-25.39) and intellectual disabilities (OR, 4.38; 95% CI, 1.58-12.17) at the time of the application were identified as significant prognostic factors in adults. Conclusions- The results of this study indicated that characteristics of Moyamoya disease such as onset type, symptoms, and imaging abnormalities differ with onset age. Prognostic analyses suggested that pediatric cases with good ADL but with infarct type onset, seizure, or sensory disorders might have a subsequent decline in ADL.

Entities:  

Keywords:  Moyamoya disease; adults; pediatrics; prognosis

Year:  2019        PMID: 31234758     DOI: 10.1161/STROKEAHA.119.024689

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  13 in total

1.  RNF213 gene polymorphism rs9916351 and rs8074015 significantly associated with moyamoya disease in Chinese population.

Authors:  Bin Zhu; Xingju Liu; Xueke Zhen; Xixi Li; Mingfen Wu; Yan Zhang; Zhigang Zhao; Dong Zhang; Jizong Zhao
Journal:  Ann Transl Med       Date:  2020-07

2.  Epidemiology of symptomatic ossification of the posterior longitudinal ligament: a nationwide registry survey.

Authors:  Takahito Fujimori; Nozomu Nakajima; Tsuyoshi Sugiura; Daisuke Ikegami; Hironobu Sakaura; Takashi Kaito; Motoki Iwasaki
Journal:  J Spine Surg       Date:  2021-12

3.  Surgical revascularization vs. conservative treatment for adult hemorrhagic moyamoya disease: analysis of rebleeding in 322 consecutive patients.

Authors:  Shaojie Yu; Nan Zhang; Jian Liu; Changwen Li; Sheng Qian; Yong Xu; Tao Yang; Nan Li; Minghui Zeng; Dongxue Li; Chengyu Xia
Journal:  Neurosurg Rev       Date:  2021-12-03       Impact factor: 3.042

4.  Causes of ischemic stroke in young adults versus non-young adults: A multicenter hospital-based observational study.

Authors:  Yuichiro Ohya; Ryu Matsuo; Noriko Sato; Fumi Irie; Kuniyuki Nakamura; Yoshinobu Wakisaka; Tetsuro Ago; Masahiro Kamouchi; Takanari Kitazono
Journal:  PLoS One       Date:  2022-07-13       Impact factor: 3.752

5.  Long-term mortality in patients with moyamoya angiopathy according to stroke presentation type in South Korea.

Authors:  Sang-Hyuk Im; Dong-Kyu Jang; Hoon Kim; Sang-Kyu Park; Kyung-Do Han
Journal:  Acta Neurochir (Wien)       Date:  2021-08-24       Impact factor: 2.216

6.  Epidemiology of Moyamoya disease in China: A nationwide hospital-based study.

Authors:  Dong Zhang; Liangran Huang; Zheng Huang; Qi Zhou; Xin Yang; Hongqiu Gu; Zixiao Li; Ying Shi; Lanxia Gan; Haibo Wang; Xvdong Ma; Yongjun Wang; Jizong Zhao
Journal:  Lancet Reg Health West Pac       Date:  2021-12-11

7.  Epigenome-Wide Association Study Reveals Differential Methylation Sites and Association of Gene Expression Regulation with Ischemic Moyamoya Disease in Adults.

Authors:  Shihao He; Xun Ye; Ran Duan; Yahui Zhao; Yanchang Wei; Yanru Wang; Ziqi Liu; Xiaokuan Hao; Xiaolin Chen; Qiang Hao; Hao Wang; Yuanli Zhao; Rong Wang
Journal:  Oxid Med Cell Longev       Date:  2022-03-24       Impact factor: 6.543

8.  Epidemiology of Moyamoya Angiopathy in Eastern India.

Authors:  Shambaditya Das; Souvik Dubey; Suman Das; Avijit Hazra; Alak Pandit; Ritwik Ghosh; Biman Kanti Ray
Journal:  Front Neurol       Date:  2022-03-04       Impact factor: 4.003

Review 9.  Mystery(n) Phenotypic Presentation in Europeans: Report of Three Further Novel Missense RNF213 Variants Leading to Severe Syndromic Forms of Moyamoya Angiopathy and Literature Review.

Authors:  Claudia Santoro; Giuseppe Mirone; Mariateresa Zanobio; Giusy Ranucci; Alessandra D'Amico; Domenico Cicala; Maria Iascone; Pia Bernardo; Vincenzo Piccolo; Andrea Ronchi; Giuseppe Limongelli; Marco Carotenuto; Vincenzo Nigro; Giuseppe Cinalli; Giulio Piluso
Journal:  Int J Mol Sci       Date:  2022-08-11       Impact factor: 6.208

10.  Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study.

Authors:  Yixin Sun; Guoyu Zhou; Jingnan Feng; Lu Chen; Guozhen Liu; Jinxi Wang; Qingliang Wang; Junyou Yu; Xiwang Yang; Zheng Yang; Pei Gao; Shengfeng Wang; Siyan Zhan
Journal:  Stroke Vasc Neurol       Date:  2021-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.